Rice Hall James & Associates’s Provention Bio, Inc. Common Stock PRVB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-72,176
| Closed | -$1.74M | – | 274 |
|
|
2023
Q1 | $1.74M | Sell |
72,176
-109,804
| -60% | -$2.65M | 0.1% | 199 |
|
|
2022
Q4 | $1.92M | Sell |
181,980
-39,621
| -18% | -$419K | 0.11% | 193 |
|
|
2022
Q3 | $997K | Sell |
221,601
-4,184
| -2% | -$18.8K | 0.06% | 233 |
|
|
2022
Q2 | $903K | Buy |
225,785
+5,720
| +3% | +$22.9K | 0.04% | 232 |
|
|
2022
Q1 | $1.61M | Buy |
220,065
+13,850
| +7% | +$101K | 0.06% | 223 |
|
|
2021
Q4 | $1.16M | Sell |
206,215
-35,196
| -15% | -$198K | 0.04% | 238 |
|
|
2021
Q3 | $1.55M | Buy |
241,411
+5,487
| +2% | +$35.1K | 0.06% | 231 |
|
|
2021
Q2 | $1.99M | Sell |
235,924
-11,271
| -5% | -$95K | 0.07% | 221 |
|
|
2021
Q1 | $2.59M | Buy |
247,195
+79
| +0% | +$829 | 0.08% | 167 |
|
|
2020
Q4 | $4.19M | Buy |
247,116
+16,243
| +7% | +$275K | 0.15% | 117 |
|
|
2020
Q3 | $2.96M | Buy |
230,873
+84,917
| +58% | +$1.09M | 0.12% | 128 |
|
|
2020
Q2 | $2.06M | Buy |
145,956
+10,804
| +8% | +$152K | 0.09% | 147 |
|
|
2020
Q1 | $1.24M | Buy |
135,152
+76,584
| +131% | +$704K | 0.07% | 181 |
|
|
2019
Q4 | $873K | Buy |
+58,568
| New | +$873K | 0.03% | 234 |
|